Press Releases

STAINES-UPON-THAMES, United Kingdom, Aug. 13, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global biopharmaceutical company, today annou

NEW YORK and BERKELEY HEIGHTS, N.J., Aug. 13, 2019 /PRNewswire/ -- CityMD, the leading urgent care provider in the New York metro area, and Summit Medical Group, one of the nation's premier independent multispecialty medical practices, today announced the completion of their merger – the first-of-its-kind between an urgent car

NEW YORK, Aug. 13, 2019 /PRNewswire/ -- The Alzheimer's Foundation of America (AFA) today announced a

WARSAW, Ind., Aug. 13, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, will participate in the Wells Fargo Securities 2019 Healthcare Conference at the Westin Copley Place in Boston.  Cole Lannum, CFA, Senior Vice President of Investor Relations, will present for th

WARRINGTON, Pa., Aug. 13, 2019 /PRNewswire/ -- Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation

DENVER, Aug. 13, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (OTCQX: MDCL) ("Medicine Man Technologies" or "Company"), today announced that the Company will host a conference call to discuss operational and financial highlights from its second quarter 2019 on Thursday, August 15, 2019 at 4:15 p.m. ET

RANCHO CORDOVA, Calif., Aug. 13, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced improved financial and operating results for the second quarter ended June 30, 2019 and provided a corpo

IRVINE, Calif., Aug. 13, 2019 /PRNewswire/ -- NKMax America, a biotechnology company harnessing the power of the body's immune system through the development of Natural Killer (NK) cell therapies, today announced that it has dosed the first subject in study SNK01-US01, a phase I clinical trial evaluating SNK, an ex vivo expanded autologous natural killer cell

LAKE FOREST, Calif., Aug. 13, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced financial results for the second quarter ended June 30, 2019.

STATESVILLE, N.C., Aug. 13, 2019 /PRNewswire/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today announced that the Company plans to release its first quarter fiscal year 2020 financial results on Tuesday, August 27, 2019 after the close of trading.  This information will be available on the Company's website